Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
391 - Are notes to HCPs allowed to be attached to PAAB material or approved studies. If not, where is this referenced in the code.
-
PAAB approved ads should be used exactly as approved otherwise it’s not really “preclearance” (e.g. without modification through inclusion of additional notes affixed to the piece). Affixing notes to independently generated materials could cause them not to be exempt. It is a best practice to have clear internal regulations either prohibiting use of notes in this manner or explaining the limited cases in which such notes can be used (e.g. best to restrict this to administrative notes like “sorry I missed you” and/or contact info).
